- Home
- DOCN vs AMRX Comparison
DOCN vs AMRX Comparison
Compare DOCN & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCN
- AMRX
- Stock Information
- Founded
- DOCN 2011
- AMRX 2002
- Country
- DOCN United States
- AMRX United States
- Employees
- DOCN N/A
- AMRX N/A
- Industry
- DOCN Retail: Computer Software & Peripheral Equipment
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- DOCN Technology
- AMRX Health Care
- Exchange
- DOCN Nasdaq
- AMRX Nasdaq
- Market Cap
- DOCN 2.5B
- AMRX 2.5B
- IPO Year
- DOCN 2021
- AMRX N/A
- Fundamental
- Price
- DOCN $28.24
- AMRX $8.33
- Analyst Decision
- DOCN Buy
- AMRX Strong Buy
- Analyst Count
- DOCN 14
- AMRX 4
- Target Price
- DOCN $40.62
- AMRX $11.50
- AVG Volume (30 Days)
- DOCN 1.5M
- AMRX 1.7M
- Earning Date
- DOCN 08-05-2025
- AMRX 08-05-2025
- Dividend Yield
- DOCN N/A
- AMRX N/A
- EPS Growth
- DOCN 119.67
- AMRX N/A
- EPS
- DOCN 1.14
- AMRX N/A
- Revenue
- DOCN $806,588,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- DOCN $15.19
- AMRX $9.84
- Revenue Next Year
- DOCN $13.99
- AMRX $7.33
- P/E Ratio
- DOCN $24.84
- AMRX N/A
- Revenue Growth
- DOCN 13.21
- AMRX 13.42
- 52 Week Low
- DOCN $25.45
- AMRX $6.50
- 52 Week High
- DOCN $47.02
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- DOCN 46.63
- AMRX 60.64
- Support Level
- DOCN $28.66
- AMRX $8.22
- Resistance Level
- DOCN $30.37
- AMRX $8.53
- Average True Range (ATR)
- DOCN 0.94
- AMRX 0.21
- MACD
- DOCN 0.16
- AMRX 0.01
- Stochastic Oscillator
- DOCN 41.02
- AMRX 76.19
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.